PACB - Pacific Biosciences of California, Inc.
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.82B |
| Enterprise Value | 3.00B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 20.12 |
| Price/Book (mrq) | 4.24 |
| Enterprise Value/Revenue | 22.38 |
| Enterprise Value/EBITDA | -9.80 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.67 |
| 52-Week Change 3 | 170.34% |
| S&P500 52-Week Change 3 | 3.90% |
| 52 Week High 3 | 14.20 |
| 52 Week Low 3 | 3.85 |
| 50-Day Moving Average 3 | 11.40 |
| 200-Day Moving Average 3 | 9.27 |
Share Statistics
| Avg Vol (3 month) 3 | 3.78M |
| Avg Vol (10 day) 3 | 4.03M |
| Shares Outstanding 5 | 249.89M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 229.37M |
| % Held by Insiders 1 | 1.70% |
| % Held by Institutions 1 | 86.58% |
| Shares Short (May 14, 2023) 4 | 24.18M |
| Short Ratio (May 14, 2023) 4 | 7.51 |
| Short % of Float (May 14, 2023) 4 | 10.81% |
| Short % of Shares Outstanding (May 14, 2023) 4 | 9.67% |
| Shares Short (prior month Apr 13, 2023) 4 | 27.18M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2022 |
| Most Recent Quarter (mrq) | Mar 30, 2023 |
Profitability
| Profit Margin | -239.32% |
| Operating Margin (ttm) | -224.97% |
Management Effectiveness
| Return on Assets (ttm) | -9.83% |
| Return on Equity (ttm) | -44.97% |
Income Statement
| Revenue (ttm) | 134.03M |
| Revenue Per Share (ttm) | 0.58 |
| Quarterly Revenue Growth (yoy) | 17.30% |
| Gross Profit (ttm) | 53.47M |
| EBITDA | -290.64M |
| Net Income Avi to Common (ttm) | -320.76M |
| Diluted EPS (ttm) | -1.51 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 874.89M |
| Total Cash Per Share (mrq) | 3.5 |
| Total Debt (mrq) | 946.73M |
| Total Debt/Equity (mrq) | 136.79 |
| Current Ratio (mrq) | 3.69 |
| Book Value Per Share (mrq) | 2.77 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -278.87M |
| Levered Free Cash Flow (ttm) | 39.74M |
© 2023 Yahoo. All rights reserved.